SEI INVESTMENTS CO - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 172 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.14 and the average weighting 0.7%.

Quarter-by-quarter ownership
SEI INVESTMENTS CO ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2024$2,283,781
-53.7%
284,761
-14.5%
0.00%
-57.1%
Q1 2024$4,937,199
+144.1%
333,148
+33.9%
0.01%
+133.3%
Q4 2023$2,022,479
+70.4%
248,766
-4.6%
0.00%
+50.0%
Q3 2023$1,186,919
-51.9%
260,868
-25.6%
0.00%
-50.0%
Q2 2023$2,469,818
+41.0%
350,821
+22.4%
0.00%
+33.3%
Q1 2023$1,751,714
-7.1%
286,691
-2.8%
0.00%
-25.0%
Q4 2022$1,885,195
-31.2%
295,022
+3.2%
0.00%
-33.3%
Q3 2022$2,740,000
-21.4%
285,981
-9.5%
0.01%
-25.0%
Q2 2022$3,487,000
-23.9%
315,913
+14.9%
0.01%
-11.1%
Q1 2022$4,580,000
-10.1%
275,012
+3.1%
0.01%
-10.0%
Q4 2021$5,094,000
-7.2%
266,771
+19.9%
0.01%
-16.7%
Q3 2021$5,489,000
-9.0%
222,404
-4.0%
0.01%
-7.7%
Q2 2021$6,032,000
-14.1%
231,623
+4.6%
0.01%
-27.8%
Q1 2021$7,023,000
-52.5%
221,442
-30.5%
0.02%
-52.6%
Q4 2020$14,779,000
+31.9%
318,527
-6.4%
0.04%
+18.8%
Q3 2020$11,207,000
+12.0%
340,374
-6.6%
0.03%
+3.2%
Q2 2020$10,008,000
+18.9%
364,564
+29.7%
0.03%0.0%
Q1 2020$8,414,000
+168.3%
281,125
+148.2%
0.03%
+244.4%
Q4 2019$3,136,000
+226.7%
113,264
+114.8%
0.01%
+350.0%
Q3 2019$960,000
-40.0%
52,727
-19.1%
0.00%
-60.0%
Q2 2019$1,599,000
+586.3%
65,197
+166.7%
0.01%
+400.0%
Q1 2019$233,00024,4490.00%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
MHR Fund Management 19,997,103$90,986,81911.15%
MPM BioImpact LLC 3,287,397$14,957,6563.99%
Perceptive Advisors 11,962,938$54,431,3671.82%
CM Management, LLC 200,000$910,0000.97%
Velan Capital Investment Management LP 250,000$1,137,5000.92%
Opaleye Management Inc. 610,000$2,775,5000.90%
Boxer Capital, LLC 3,705,133$16,858,3550.90%
SECTORAL ASSET MANAGEMENT INC 985,000$4,481,7500.87%
Parametrica Management Ltd 95,400$434,0700.73%
683 Capital Management, LLC 2,050,000$9,327,5010.72%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders